ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
First Patient Dosed in DSP-0509 Trial
americanpharmaceuticalreview
September 14, 2018Boston Biomedical has initiated clinical trial activities for DSP-0509, an investigational Toll-like receptor (TLR) 7 agonist. DSP-0509 is hypothesized to induce cytokine production, activate cytotoxic T lymphocytes, and sustain the immune-mediated antitu
Pharma Sources Insight January 2025
